Cronos Group Inc. (CRON.TO)

CAD 2.59

(1.57%)

Revenue Summary of Cronos Group Inc.

Cronos Group Inc.'s latest annual revenue in 2023 was 87.24 Million USD , down -5.07% from previous year.
Cronos Group Inc.'s latest quarterly revenue in 2024 Q1 was 25.28 Million USD , up 5.74% from previous quarter.
Cronos Group Inc. reported a annual revenue of 91.9 Million USD in annual revenue 2022, up 23.47% from previous year.
Cronos Group Inc. reported a annual revenue of 74.43 Million USD in annual revenue 2021, up 59.32% from previous year.
Cronos Group Inc. reported a quarterly revenue of 25.28 Million USD for 2024 Q1, up 5.74% from previous quarter.
Cronos Group Inc. reported a quarterly revenue of 20.14 Million USD for 2023 Q1, down -11.98% from previous quarter.

Annual Revenue Chart of Cronos Group Inc. (2023 - 2013)

Historical Annual Revenue of Cronos Group Inc. (2023 - 2013)

Year	Revenue	Revenue Growth
2023	87.24 Million USD	-5.07%
2022	91.9 Million USD	23.47%
2021	74.43 Million USD	59.32%
2020	46.71 Million USD	96.71%
2019	23.75 Million CAD	106.0%
2018	11.52 Million CAD	255.17%
2017	3.24 Million CAD	687.28%
2016	412.32 Thousand CAD	81.97%
2015	226.58 Thousand CAD	0.0%
2014	- CAD	100.0%
2013	-195.61 Thousand CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	27.76 Million USD	9.78%
2024 Q1	25.28 Million USD	5.74%
2023 Q1	20.14 Million USD	-11.98%
2023 FY	87.24 Million USD	-5.07%
2023 Q4	23.91 Million USD	-3.61%
2023 Q3	24.81 Million USD	30.43%
2023 Q2	19.02 Million USD	-5.57%
2022 Q2	23.06 Million USD	-7.88%
2022 FY	91.9 Million USD	23.47%
2022 Q1	25.03 Million USD	-2.95%
2022 Q4	22.88 Million USD	9.39%
2022 Q3	20.92 Million USD	-9.27%
2021 Q4	25.79 Million USD	26.4%
2021 Q1	12.61 Million USD	-26.02%
2021 FY	74.43 Million USD	59.32%
2021 Q3	20.4 Million USD	30.63%
2021 Q2	15.62 Million USD	23.88%
2020 Q2	9.88 Million USD	17.21%
2020 Q1	8.43 Million USD	15.38%
2020 Q4	17.04 Million USD	50.08%
2020 Q3	11.35 Million USD	14.92%
2020 FY	46.71 Million USD	96.71%
2019 Q3	9.59 Million CAD	23.03%
2019 FY	23.75 Million CAD	106.0%
2019 Q4	7.3 Million CAD	-23.82%
2019 Q2	7.79 Million CAD	60.92%
2019 Q1	4.84 Million CAD	30.52%
2018 Q1	2.28 Million CAD	81.89%
2018 Q4	3.71 Million CAD	27.57%
2018 FY	11.52 Million CAD	255.17%
2018 Q3	2.91 Million CAD	12.77%
2018 Q2	2.58 Million CAD	13.16%
2017 Q3	1.05 Million CAD	114.03%
2017 FY	3.24 Million CAD	687.28%
2017 Q4	1.25 Million CAD	18.36%
2017 Q2	494.94 Thousand CAD	28.47%
2017 Q1	385.24 Thousand CAD	21.04%
2016 Q1	-11.41 Thousand CAD	0.0%
2016 FY	412.32 Thousand CAD	81.97%
2016 Q4	318.27 Thousand CAD	238.43%
2016 Q3	94.04 Thousand CAD	0.0%
2016 Q2	- CAD	100.0%
2015 Q2	- CAD	0.0%
2015 FY	226.58 Thousand CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 Q1	- CAD	0.0%
2014 FY	- CAD	100.0%
2014 Q3	- CAD	0.0%
2014 Q2	- CAD	0.0%
2013 FY	-195.61 Thousand CAD	0.0%
2013 Q2	- CAD	0.0%
2013 Q3	- CAD	0.0%

Peer Revenue Comparison of Cronos Group Inc.

Name	Revenue	Revenue Difference
Aurora Cannabis Inc.	270.28 Million CAD	67.722%
Avicanna Inc.	16.79 Million CAD	-419.555%
Avant Brands Inc.	26.34 Million CAD	-231.161%
Cardiol Therapeutics Inc.	- CAD	-Infinity%
Crescita Therapeutics Inc.	17.52 Million CAD	-397.894%
Knight Therapeutics Inc.	328.19 Million CAD	73.418%
MediPharm Labs Corp.	33.06 Million CAD	-163.871%
OrganiGram Holdings Inc.	149.2 Million CAD	41.53%
Canopy Growth Corporation	297.14 Million CAD	70.64%
Willow Biosciences Inc.	1.17 Million CAD	-7343.771%
Auxly Cannabis Group Inc.	101.07 Million CAD	13.689%